Covishield and Covaxin have no doubts on safety, says VK Paul
Pune-based Serum Institute of India’s (SII) Covishield and Hyderabad-based Bharat Biotech’s Covaxin have been given the emergency use authorization based on restriction and there needs to be no dilemma adhering to their safety and efficacy said Dr VK Paul, Member (Health), NITI Aayog on Tuesday. VK Paul further added that the two vaccines against Covid-19…